Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Probir Chakravarty

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Nature|August 30, 2019
Metastatic-niche labelling reveals parenchymal cells with stem featuresLuigi Ombrato, Emma Nolan, Ivana Kurelac, et al.
Science (New York, N.Y.)|October 7, 2016
The linker histone H1.0 generates epigenetic and functional intratumor heterogeneityCristina Morales Torres, Alva Biran, Matthew J Burney, et al.
Nature|November 14, 2019
Author Correction: Metastatic-niche labelling reveals parenchymal cells with stem featuresLuigi Ombrato, Emma Nolan, Ivana Kurelac, et al.
Nature Immunology|April 12, 2024
Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitisMarisol Alvarez-Martinez, Luke S Cox, Claire F Pearson, et al.
Cell|June 3, 2021
Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunityEvangelos Giampazolias, Oliver Schulz, Kok Haw Jonathan Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2011
Interleukin-6 as a therapeutic target in human ovarian cancerJermaine Coward, Hagen Kulbe, Probir Chakravarty, et al.
The Journal of Clinical Investigation|March 22, 2022
PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphomaAnnalisa D'Avola, Nathalie Legrave, Mylène Tajan, et al.
Nature Communications|November 5, 2020
Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosisLúcia Moreira-Teixeira, Philippa J Stimpson, Evangelos Stavropoulos, et al.
The Journal of Clinical Investigation|February 15, 2024
PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphomaAnnalisa D'Avola, Nathalie Legrave, Mylène Tajan, et al.
Cancer Research|November 9, 2011
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironmentHagen Kulbe, Probir Chakravarty, D Andrew Leinster, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Nature|August 30, 2019
Metastatic-niche labelling reveals parenchymal cells with stem featuresLuigi Ombrato, Emma Nolan, Ivana Kurelac, et al.
Science (New York, N.Y.)|October 7, 2016
The linker histone H1.0 generates epigenetic and functional intratumor heterogeneityCristina Morales Torres, Alva Biran, Matthew J Burney, et al.
Nature|November 14, 2019
Author Correction: Metastatic-niche labelling reveals parenchymal cells with stem featuresLuigi Ombrato, Emma Nolan, Ivana Kurelac, et al.
Nature Immunology|April 12, 2024
Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitisMarisol Alvarez-Martinez, Luke S Cox, Claire F Pearson, et al.
Cell|June 3, 2021
Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunityEvangelos Giampazolias, Oliver Schulz, Kok Haw Jonathan Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2011
Interleukin-6 as a therapeutic target in human ovarian cancerJermaine Coward, Hagen Kulbe, Probir Chakravarty, et al.
The Journal of Clinical Investigation|March 22, 2022
PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphomaAnnalisa D'Avola, Nathalie Legrave, Mylène Tajan, et al.
Nature Communications|November 5, 2020
Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosisLúcia Moreira-Teixeira, Philippa J Stimpson, Evangelos Stavropoulos, et al.
The Journal of Clinical Investigation|February 15, 2024
PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphomaAnnalisa D'Avola, Nathalie Legrave, Mylène Tajan, et al.
Cancer Research|November 9, 2011
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironmentHagen Kulbe, Probir Chakravarty, D Andrew Leinster, et al.
Pageof 11